Clinical trial
Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence
NCT00385268 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00385268 |
|---|---|
| Title | Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence |
| Official title | A Phase II, Double-Blind, Placebo-controlled, Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence |
| Acronym | CAMPRAL |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine Dependence |
| Intervention type | Drug |
| Interventions | acamprosate, placebo |
| Enrollment | 60 |
| Start date | Nov 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Oct 9, 2006 |
| Last update posted | Jul 10, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: